Opportunity Information: Apply for PA 10 268
Apply for PA 10 268
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Neuroscience Research on Drug Abuse (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Aug 20, 2010 and posted on Aug 20, 2010.
- Applicants must submit their applications by Sep 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments Independent school districts Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Public housing authorities/Indian housing authorities County governments City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Neuroscience Research on Drug Abuse (R01) is a National Institutes of Health funding opportunity from the National Institute on Drug Abuse (NIDA) that supports investigator-initiated research projects aimed at explaining how drug abuse and addiction work at a mechanistic level. The focus is broad across the addiction cycle, including drug use, the development of dependence, progression to addiction, withdrawal processes, and treatment-related mechanisms. Proposed studies can use a wide range of approaches and settings, including laboratory model systems, animal studies, and human research, as long as the work is clearly tied to improving scientific understanding of the biological, behavioral, and neurobiological processes that underlie substance use disorders.
The award mechanism is the NIH Research Project Grant (R01), which is typically used for mature, hypothesis-driven projects with a defined set of aims and a multi-year plan. This announcement is part of a coordinated set of opportunities with the same scientific scope but different grant mechanisms: PA-10-269 supports R21 applications (often used for exploratory or high-risk, early-stage ideas), and PA-10-270 supports R03 applications (small grants for pilot or limited-scope projects). In practical terms, applicants should choose the mechanism that best matches the maturity, scale, and risk profile of the proposed work, with PA-10-268 being the pathway for full-scale R01 research projects.
Funding levels and the number of awards are not preset. NIDA indicates that award size and project duration will vary depending on the scientific scope and needs of each application, and that total funding and award counts will ultimately depend on the number of submissions, their quality, the requested budgets, and how long the projects run. Applicants may request a project period of up to five years, with budgets described as costs appropriate for the project, meaning proposals are expected to justify resources based on what is necessary to complete the planned research rather than fitting into a single fixed cap described in the summary.
Eligibility is broad and includes many types of organizations. Eligible applicants span public and private institutions of higher education, nonprofits (including both 501(c)(3) organizations and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and multiple levels of government such as state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The announcement also explicitly includes tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments), along with tribally controlled colleges and universities. Additional eligible categories include Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, US territories or possessions, and non-US entities (foreign organizations), reflecting NIH's willingness to fund scientifically strong addiction neuroscience work across a wide institutional landscape. The opportunity does not require cost sharing or matching.
Key administrative details identify this as discretionary grant funding under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The funding opportunity number is PA-10-268, it was posted on August 20, 2010, and it had an original and current closing date of September 7, 2013, with an archive date of October 8, 2013, indicating the announcement is no longer active but remains available for reference. Applicants looking for the original full text and requirements were directed to the NIH Grants Guide page (http://grants.nih.gov/grants/guide/pa-files/PA-10-268.html). For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the Neuroscience Research on Drug Abuse (R01) opportunity?
Neuroscience Research on Drug Abuse (R01) is a National Institutes of Health (NIH) funding opportunity from the National Institute on Drug Abuse (NIDA). It supports investigator-initiated research projects aimed at explaining how drug abuse and addiction work at a mechanistic level.
Which NIH institute is sponsoring this opportunity?
This opportunity is sponsored by the National Institute on Drug Abuse (NIDA) under NIH.
What is the funding opportunity number (FOA number)?
The funding opportunity number is PA-10-268.
What grant mechanism does this announcement use?
This announcement uses the NIH Research Project Grant (R01) mechanism, which is typically used for mature, hypothesis-driven projects with a defined set of aims and a multi-year plan.
What kinds of research does this opportunity support?
It supports neuroscience and related research on drug abuse and addiction that is clearly tied to improving scientific understanding of the biological, behavioral, and neurobiological processes underlying substance use disorders.
What parts of addiction are within scope for proposed studies?
The focus is broad across the addiction cycle, including drug use, the development of dependence, progression to addiction, withdrawal processes, and treatment-related mechanisms.
Do projects have to focus on mechanisms?
Yes. The stated aim of the opportunity is to explain how drug abuse and addiction work at a mechanistic level.
What research approaches and settings are allowed?
Proposed studies can use a wide range of approaches and settings, including laboratory model systems, animal studies, and human research, as long as the work is clearly tied to mechanistic understanding of substance use disorders.
Is this an investigator-initiated program?
Yes. The announcement supports investigator-initiated research projects.
How does PA-10-268 relate to other NIH opportunities mentioned?
This announcement is part of a coordinated set of opportunities with the same scientific scope but different grant mechanisms. PA-10-269 supports R21 applications, and PA-10-270 supports R03 applications.
How should an applicant choose between R01, R21, and R03 for this scope?
Applicants are expected to choose the mechanism that best matches the maturity, scale, and risk profile of the proposed work. PA-10-268 is the pathway for full-scale R01 research projects, while PA-10-269 (R21) is often used for exploratory or high-risk, early-stage ideas, and PA-10-270 (R03) supports small grants for pilot or limited-scope projects.
Are funding levels or the number of awards fixed?
No. NIDA indicates that funding levels and the number of awards are not preset and will depend on factors including the number of submissions, their quality, requested budgets, and project durations.
What is the maximum project period allowed?
Applicants may request a project period of up to five years.
Is there a stated budget cap?
No fixed cap is described in the provided summary. Budgets are described as costs appropriate for the project, meaning applicants are expected to justify resources based on what is necessary to complete the planned research.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
Who is eligible to apply?
Eligibility is broad and includes many organization types, including public and private institutions of higher education; nonprofits (including 501(c)(3) organizations and certain nonprofits without 501(c)(3) status); for-profit organizations (including small businesses and other for-profits); and multiple levels of government.
Are government entities eligible to apply?
Yes. Eligible government applicants include state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities.
Are tribal governments and tribal organizations eligible?
Yes. The announcement explicitly includes federally recognized tribal governments, tribal organizations (including those other than federally recognized tribal governments), and tribally controlled colleges and universities.
Are minority-serving institutions included in eligibility?
Yes. The eligible categories listed include Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, and Historically Black Colleges and Universities (HBCUs).
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are explicitly listed among the eligible categories.
Can federal agencies apply?
Yes. Eligible federal agencies are included among the eligible applicant categories.
Are non-U.S. (foreign) organizations eligible?
Yes. The eligible categories include non-U.S. entities (foreign organizations).
What type of funding is this considered?
The announcement is identified as discretionary grant funding.
What is the CFDA number associated with this opportunity?
The CFDA number is 93.279, titled Drug Abuse and Addiction Research Programs.
When was this opportunity posted?
It was posted on August 20, 2010.
What were the closing and archive dates?
The original and current closing date was September 7, 2013, and the archive date was October 8, 2013.
Is this funding opportunity still active?
No. Based on the closing and archive dates provided, the announcement is no longer active and remains available for reference.
Where can someone find the original full text of the announcement?
The original full text and requirements were directed to the NIH Grants Guide page at http://grants.nih.gov/grants/guide/pa-files/PA-10-268.html.
Who is the contact for technical access issues?
For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Neuroscience Research on Drug Abuse (R21)
Previous opportunity: Senior Crisis Management Seminar
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 10 268
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 10 268) also looked into and applied for these:
| Funding Opportunity |
|---|
| Neuroscience Research on Drug Abuse (R21) Apply for PA 10 269 Funding Number: PA 10 269 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse (R03) Apply for PA 10 270 Funding Number: PA 10 270 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R21/R33) Apply for PAS 10 274 Funding Number: PAS 10 274 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR R41 Apply for RFA DA 11 004 Funding Number: RFA DA 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Developing and Improving Institutional Animal Resources (G20) Apply for RFA RR 10 011 Funding Number: RFA RR 10 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44) Apply for RFA CA 10 013 Funding Number: RFA CA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21) Apply for RFA DA 11 007 Funding Number: RFA DA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 10 283 Funding Number: PAR 10 283 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR U43/U44) Apply for PAR 10 286 Funding Number: PAR 10 286 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 11 002 Funding Number: RFA DA 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre Application for the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 287 Funding Number: PAR 10 287 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Resource Related Research Projects for Development of Animal Models and Related Materials (R24) Apply for PAR 10 289 Funding Number: PAR 10 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 10 290 Funding Number: PA 10 290 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 10 291 Funding Number: PA 10 291 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Tumor Microenvironment Network (TMEN) (U54) Apply for RFA CA 10 021 Funding Number: RFA CA 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $700,000 |
| Animal and Biological Material Resource Centers (P40) Apply for PAR 11 001 Funding Number: PAR 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 11 005 Funding Number: PAR 11 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001 Funding Number: RFA CA 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009 Funding Number: PA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008 Funding Number: PA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 268", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.